Calcipotriene Cream

ALL
News
Opinion
Photos
Videos

Jump to

Glenmark gains 2% on USFDA final nod for psoriasis drug

Glenmark Pharmaceuticals Inc. USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Calcipotriene Cream, 0.005%, the therapeutic equivalent of Dovonex Cream, 0.005% of Leo Pharma A/S.
Glenmark up 2.5% on tentative USFDA nod for psoriasis cream

Shares of Glenmark Pharmaceuticals climbed 2.55 percent intraday Monday on getting tentative approval from the US health regulator for generic Calcipotriene cream.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Calcipotriene Cream

Glenmark gains 2% on USFDA final nod for psoriasis drug

Glenmark up 2.5% on tentative USFDA nod for psoriasis cream